acetylshikonin has been researched along with interleukin-8 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, BH; Choi, YW; Jung, JE; Jung, YH; Kim, DJ; Lee, JH; Park, HR; Woo, BH | 1 |
| Hong, S; Jung, SH; Kang, TK; Kim, KA; Ko, H; Kwon, H; Le, TT; Lee, WB; Park, G | 1 |
2 other study(ies) available for acetylshikonin and interleukin-8
| Article | Year |
|---|---|
Acetylshikonin suppresses invasion of Porphyromonas gingivalis‑infected YD10B oral cancer cells by modulating the interleukin-8/matrix metalloproteinase axis.
Topics: Anthraquinones; Bacteroidaceae Infections; Cell Line, Tumor; Cells, Cultured; Epithelial-Mesenchymal Transition; Gene Expression; Humans; Interleukin-8; Matrix Metalloproteinases; Mouth Neoplasms; Porphyromonas gingivalis | 2018 |
Lithospermum erythrorhizon Siebold & Zucc. extract reduces the severity of endotoxin-induced uveitis.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Endotoxins; Humans; Inflammation; Interferon Regulatory Factors; Interleukin-6; Interleukin-8; Lipopolysaccharides; Lithospermum; Mice; NF-kappa B; Rats; Transcription Factor AP-1; Tumor Necrosis Factor-alpha; Uveitis | 2023 |